TrialJournal of translational medicine2020

A phase 2 study of combined chemo-immunotherapy with cisplatin-pembrolizumab and radiation for unresectable vulvar squamous cell carcinoma.

Oladapo Yeku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.